Is immuno-expression of E-cadherin really a prognostic factor in head and neck cancer?

Oral Oncology

Volumn 49, Issue 3, 2013, Pages

  Dayan, Dan ^a   Vered, Marilena ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; UVOMORULIN;

CANCER PROGNOSIS; CANCER STATISTICS; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LARYNX CANCER; LETTER; MOLECULAR BIOLOGY; MOUTH CAVITY; OROPHARYNX CANCER; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CADHERINS; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; TUMOR MARKERS, BIOLOGICAL;

EID: 84873406684     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.10.007     Document Type: Letter

References (7)

1. Z.G. Zhao, J. Ge, and Y.N. Sun Is E-cadherin immunoexpression a prognostic factor for head and neck squamous cell carcinoma (HNSCC)? A systematic review and meta-analysis Oral Oncol 48 2012 761 767
2. A. Jemal, F. Bray, and M.M. Center Global cancer statistics CA Cancer J Clin 61 2011 69 90
3. M.P. Rethman, W. Carpenter, and E.E. Cohen Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas J Am Dent Assoc 141 2010 509 520
4. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics CA Cancer J Clin 62 2012 10 29
5. C.R. Leemans, J.M. Boudewijn, and B.M. Braakhuis The molecular biology of head and neck cancer Nat Rev Cancer 11 2011 9 22
6. M. Vered, D. Dayan, and T. Salo The role of the tumour microenvironment in the biology of head and neck cancer: lessons from mobile tongue cancer Nat Rev Cancer 11 2011 382
7. M. Vered, I. Allon, and A. Buchner E-cadherin in oral SCC: an analysis of the confusing literature and new insights related to its immunohistochemical expression Histol Histopathol 27 2012 141 150